The MM+M Podcast

Reporter Heerea Rikhraj talks with Sommer Bazuro, PhD, chief medical officer at IPG Health, Ricki Fairley, CEO of TOUCH, The Black Breast Cancer Alliance and Dr. Adriana Kahn, Yale School of Medicine about why women receiving breast cancer diagnoses at a younger age in 2025, and how campaigns and education efforts need to evolve to prevent these diagnoses for younger women.  Check us out at: mmm-o...

Hosted by MM+M, this episode brings together Oliver Nelson, managing director at Evolvics, powered by Syneos Health, and Chris Tuleya, EVP of media at Evolvics, for a candid conversation on why most brands are getting media reporting wrong. Too often, marketers focus on vanity metrics such as clicks and impressions, numbers that look good on a dashboard but fail to connect with real business outco...

The 2025 MM+M Media Summit is back! As such, our focus for this week’s episode is the state of health media. To help us navigate an industry in flux, at a crossroads, under a microscope – whatever your analogy of choice – is Bill Veltre, head of media at Deerfield Group. Leading media operations for a 2025 MM+M Agency 100 honoree , Veltre walks us through the obstacles posed by a growing amount of...

Reporter Heerea Rikhraj chats with journalist and author Tamsen Fadal about her book, How to Menopause , her menopause documentary The M Factor and how health marketers can bridge the gap between knowledge and awareness of the condition.  Check us out at: mmm-online.com   Follow us:  YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M  ...

In this episode, we explore how the consumerization of healthcare has pharma thinking more like retailers. RVO Health’s Suzy Jackson joins us to talk about its new digital health division and what “direct-to-patient” really means for the patient experience. Plus, who’s driving this shift inside pharma, and the one piece of advice every brand should take into 2026. Check us out at: mmm-online.com  ...

With the 2025-26 NHL season underway, the Florida Panthers have set out to accomplish a three-peat. Meanwhile, AstraZeneca has another goal in mind. The British pharma giant is continuing with its decades-long Get Body Checked Against Cancer campaign. With the assistance of agency partner Grey Health , AstraZeneca is on an ongoing quest to eradicate the stigma around getting screened for cancer an...

Following a very successful 2025 MM+M Awards , we bring you a special two-part episode. This week, reporter Heerea Rikhraj brings us an insightful conversation with Blueprint Audiences co-founder Jeremy Mittler about how to reach target audiences while still protecting health data. In lieu of our regular Trends segments, we bring you some additional audio from the MM+M Awards. This includes Titani...

Broadcasting from the floor of the Cipriani Wall Street, managing editor Jack O’Brien and editor-at-large Steve Madden spoke with executives from agencies and pharma brands celebrating medical marketing’s biggest night. Listen to what medical marketing leaders told MM+M about the top industry trends before 2025 MM+M Awards got underway.   Check us out at: mmm-online.com   Follow us:  You...

Thursday is the year’s biggest night in medical marketing. Ahead of the 2025 MM+M Awards , Jury Chair Meghan Rivera discusses the top pharma advertising work nominated for honors. Without spoiling the results, Rivera provides industry leaders with a sense of what differentiated some of the health submissions from the rest of the field and earned accolades. Then during the Trends segment, members o...

In this new series, MM+M explores the growing presence of private equity in the healthcare world. Host Heerea Rikhraj connects with Tom Donnelly of Supreme Group and Liz Kanter of Pivot Design to explore how private equity is transforming healthcare marketing. They share how their partnership with Trinity Hunt formed, how it enabled growth and how it helped them access resources while keeping crea...

It’s been just over a week since the Trump administration very publicly claimed that Tylenol usage is linked to an increased rate of autism. Based on dubious evidence, the White House asserted that acetaminophen – the active ingredient in Tylenol – is what’s behind the “current autism epidemic.” For all of the bluster and upheaval that arose from the communications coming out of 1600 Pennsylvania...

Medical marketing is faced with gale-force winds of uncertainty, so we’re going to spend most of this week’s episode focused on the industry’s future but in two distinct ways. For our feature interview, we’re joined by recurring guest Andrea Palmer , the CEO of Publicis Health Media , as well as Brad Liebow , who recently jumped from Spark Foundry to become PHM’s first chief investment officer. Th...

If there are two topics medical marketers can’t get enough of, it’s GLP-1s and the ongoing crackdown on DTC pharma ads.  This week’s episode of the MM+M Podcast delves into what happens when patients stop taking GLP-1s as well as how the first week of the Trump administration’s enhanced enforcement of restrictions on DTC pharma ads has gone. To start the episode, reporter Heerea Rikhraj brings us...

In this episode, we explore the story behind the Empathy Engine — Syneos Health Communications’ groundbreaking consumer data hub that's transforming the way healthcare brands connect with people. Built at the intersection of behavioral science and emotional insight, the Empathy Engine reveals the "why" behind health decisions. Hear from the minds behind the Engine and learn how it’s helping market...

Hidradenitis suppurativa (HS) is, by all accounts, a painful disease. An estimated 3 million Americans live with HS, which is most commonly identified by flare ups as well as painful and unflattering lumps under the skin. Over the past few years, drugmakers have launched campaigns and marketing efforts to bring greater attention and understanding to the disease. Recently, Incyte launched HS Truths...

Managing editor Jack O’Brien talks with medical marketer turned mental health warrior Jon Nelson and neuroscientist Dr. Rachel Wurzman about their consulting firm NeuroLivd. The organization is dedicated to infusing lived experience perspectives into the mental health, wellness and neurological space – fueled by their passion and substance as well as rooted in their own deep lived experience withi...

Alexion recently launched the second film in its Rare Connections series, Rare Connections in gMG . Managing editor Jack O’Brien talks with Lucid Diagnostics' chief technology and compliance officer Dr. Brian deGuzman about the company’s nationwide initiative to provide education and testing for esophageal precancer. He explains how the NFLPA factors into the effort, which launched in Cincinnati,...

Explore the latest trends in HCP content consumption and how pharma marketers can adapt their strategies to reach their target audience effectively with The Trade Desk's senior director of business development Lindsay Reardon and Swoop's VP of client success Kevin Elwell.  They will share research insights into how HCPs engage online, highlighting the growing importance of CTV and audio channels,...

Are you ready for some football? The 2025 NFL season kicks off this week with the defending champion Philadelphia Eagles hosting the Dallas Cowboys on Thursday night. The highest linear TV ratings are usually delivered by live sports broadcasts and no entity is a more reliable generator for eyeballs than the NFL. It should then come as no surprise that drugmakers want to intensify their relationsh...

Video games are big fun and even bigger money. The International Trade Administration estimated that the value of the global video game industry in 2023 was $184 billion – with more than 3.2 billion gamers worldwide.  Recognizing this new trend in media consumption and content engagement, medical marketers have been trying to break through in the gaming world. Few have had as much success as Level...

Just over two years ago, the FDA issued its first draft guidance on clinical trials with psychedelic drugs. Now, HHS has hired a dedicated psychedelics advisor.  This week, Reunion Neuroscience reported a mid-stage success with its short-acting psychedelic drug in postpartum depression. At a moment of increasing momentum – both in terms of research, funding and commercial promise – behind psychede...

Alexion recently launched the second film in its Rare Connections series, Rare Connections in gMG . Managing editor Jack O’Brien talks with Christophe Hotermans, Alexion’s head of global medical affairs, about the multimedia effort to raise the profile of gMG. For this week’s MM+M Fast Break, Hotermans discusses the drugmaker’s latest rare disease-focused film. Check us out at: mmm-online.com &nbs...

Every year at Haymarket Media , we bring in a cohort of about 30 interns for eight weeks over the summer to learn the ropes across our business media, medical communications and internal operations units. For us here at MM+M , our intern exit interview gets recorded and sent out into the world.  Over the past few weeks on the podcast, you’ve heard from our summer intern, Lola Offenback . In additi...

MM+M summer intern Lola Offenback sits down with Derrick Gastineau to discuss Currax Pharmaceuticals’ latest human-centered campaign, Real Patients, Real Results. Gastineau emphasized the importance of authentic patient voices in marketing. He explains the selection process for patient stories, Currax’s unique position in the weight loss market and how they measure the campaign's success through e...

Reporter Heerea Rikhraj sits down with Dr. Alftan Dyson to discuss the high rates of HIV amongst Black communities.  Dr. Dyson discusses treatments like PrEP, which the Centers of Disease Control and Prevention estimates that around 2.2 million people in the U.S. need, up from previous estimates of 1.2 million. Dr. Dyson delves into the initiatives ViiV Healthcare is working on to tackle this issu...